What a fructosamine test costs depends on the panel it is bundled into, the laboratory and assay used, and whether it is ordered through a clinic, a hospital or a direct-to-consumer membership. The marker itself is a routine chemistry assay. On this page, the current price is shown with the panel details.
Fructosamine is rarely bought as a lone test, because the number says far more when it is read beside fasting glucose, insulin and HbA1c. Here it sits inside the Extended Metabolic panel, which is HSA/FSA eligible. Coverage through a health plan varies by plan and by the reason the test was ordered, so check with your plan rather than assuming either way.
Fructosamine is a laboratory measure of glycated serum proteins, mostly albumin, and it reflects average blood glucose over roughly the previous two to three weeks.
Glucose in the bloodstream attaches to proteins slowly and without an enzyme driving it. The more glucose that has been circulating, and the longer it has been there, the larger the glycated fraction becomes. Because serum albumin is replaced much faster than red blood cells are, the glycated fraction of albumin resets on a shorter cycle, which is why reviews of the biochemistry describe fructosamine and glycated albumin as short-window markers of glucose exposure 1. Fructosamine is the broader, older assay; glycated albumin is the specific protein fraction that makes up most of what the fructosamine assay detects, and laboratory-medicine reviews treat the two as closely related measures of the same process 2.
If you want the marker page rather than the pricing explanation, the Fructosamine entry covers what the value represents and how it is reported. One practical point to carry into any cost comparison: the fructosamine assay is not standardised across laboratories the way HbA1c is, so the reference interval printed on your report belongs to the laboratory that ran it, and results from two different laboratories are not always directly comparable.
The two tests answer different questions. HbA1c describes glucose exposure over roughly the past two to three months, while fructosamine describes roughly the past two to three weeks, so the shorter marker picks up recent change that the longer one has not yet absorbed.
| Fructosamine (glycated serum protein) | HbA1c | |
|---|---|---|
| Window reflected | About two to three weeks | About two to three months |
| Protein measured | Albumin and other serum proteins | Haemoglobin inside red blood cells |
| Distorted by | Altered albumin turnover, protein loss, low serum protein states | Shortened or lengthened red cell lifespan, anaemia, haemoglobin variants |
| Assay standardisation | Varies by laboratory and method | Internationally standardised |
| Typical use | Tracking short-term change, or when HbA1c is hard to interpret | Long-term glucose control and diagnosis |
The clearest case for the shorter marker is when red blood cell behaviour makes HbA1c unreliable. Research suggests that, in the chronic kidney disease and dialysis population, HbA1c can misrepresent true glucose control, and that glycated albumin or continuous glucose monitoring may give a closer picture 3. The physiological reasons for that mismatch in kidney disease have been reviewed in detail, including shortened red cell survival and altered protein handling 4.
For detecting dysglycaemia in the general case, the picture is less settled. Comparative reviews of HbA1c, fructosamine and glycated albumin as screening tools suggest that each has different strengths and that none replaces the others outright 5, and a meta-analysis of diagnostic test accuracy found that glycated albumin performs reasonably as a diagnostic marker while still varying with the cut-off and population studied 6. One analysis framed the practical question directly, asking whether glycated albumin is an alternative to established tests or an additional one, and concluded that its value is clearest as a complement rather than a replacement 7. That is the reason most buyers end up comparing panels rather than single assays.
Very little of what you pay tracks the chemistry. The same marker can carry quite different costs depending on how the order reaches the laboratory and what travels with it.
| Factor | Why it moves the cost |
|---|---|
| How the order is placed | A test ordered during a clinic or hospital visit carries the cost of that visit and any facility charge. A test ordered as part of a prepaid panel does not. |
| Bundling | Markers priced inside a panel are usually cheaper per marker than the same markers added one at a time, because the draw, handling and reporting are shared. |
| The drawing site | Phlebotomy, specimen handling and courier logistics are often itemised separately from the assay, and vary by site. |
| The assay and the laboratory | Fructosamine can be run by more than one method, and reference laboratories price differently from hospital laboratories. |
| Add-on markers | Fructosamine alone leaves a lot unanswered, so it is commonly ordered with glucose, insulin and HbA1c, which changes the total. |
| Testing frequency | A short-window marker is most useful repeated. A one-off price and a year of retesting are different numbers. |
| Insurance pathway | Coverage varies by plan and by why the test was ordered, and a test billed through a plan can land very differently from one bought outright. Check with your plan. |
| Tax-advantaged payment | HSA and FSA eligibility does not lower a price, but it changes which dollars pay it. The Extended Metabolic panel is HSA/FSA eligible. |
Two habits save more than shopping the marker does. First, price the panel, not the line item, because the per-marker figure only makes sense once the draw and reporting are included. Second, price the year rather than the single draw, since a marker that reflects two to three weeks is being asked to show movement, and movement needs more than one data point.
Fructosamine is grouped with the rest of the glucose-handling picture inside the Extended Metabolic panel rather than sold on its own, and the panel page lists the exact markers included alongside the current price. The logic is simple: a short-window glycation marker is interpretable mainly in context, next to fasting glucose, insulin and the longer-window marker it is being compared against.
FitScript is a labs-first membership, with 150+ biomarkers tested per year, interpretation by Atlas, its AI health advisor, and any treatment decision made by a licensed provider after reviewing the member. For a marker like this one, the repeat testing matters as much as the first result. A single fructosamine value tells you something about the past few weeks. A series tells you whether anything you changed in diet, training, sleep or body composition actually moved glucose exposure, and it does so on a faster cycle than HbA1c allows.
Preparation depends on what else is on the panel, not on fructosamine itself. Glycated proteins reflect weeks of glucose exposure, so a single meal does not meaningfully shift the value, but companion markers such as fasting glucose, insulin and lipids do have their own requirements.
Follow the preparation instructions issued with your specific order, since those are written for the exact marker set being run. In general terms, keep the week before the draw representative rather than unusual, take your medications and supplements as your prescriber directed unless that prescriber tells you otherwise, stay normally hydrated, and tell the drawing site about any condition affecting your kidneys, liver, thyroid or protein levels, since those can influence how a protein-based glycation marker reads. If you are retesting to track a change, try to repeat the draw under similar conditions, because consistency between draws is what makes the comparison meaningful.
Read it as an observation about recent glucose exposure, not as a verdict. A value above your laboratory's reference interval means more of your circulating protein has been glycated over the past few weeks than the comparison population, which may reflect higher average glucose, and it may also reflect something unrelated to glucose, such as altered albumin turnover or low serum protein. A value below the interval can reflect faster protein turnover rather than better control. Either way, the marker describes a pattern, not a diagnosis, and a suboptimal value is a reason to look at the rest of the panel with a clinician rather than to draw a conclusion alone.
The interest in these markers is not purely about convenience. Reviews of glycated albumin as a clinical biomarker report that it carries information about glucose variability that longer-window markers smooth over 8, and separate reviews of its clinical usefulness reach a similar position about short-term monitoring 9. In cardiovascular settings, higher glycated albumin is associated with worse outcomes among patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention 10. Less invasive versions are being explored as well, and a systematic review of salivary fructosamine as a glycaemic biomarker concluded that the evidence base is still early 11.
This page is educational and is not medical advice. Share your results, and any treatment question they raise, with a clinician or licensed provider who can evaluate your full history, and contact a clinician promptly about any result flagged as outside the standard range.
Related reading on this site: the Fructosamine biomarker page explains what the value represents, and the Extended Metabolic panel page lists the markers included and shows the current price.
There is no single figure, because the marker is almost always sold inside a panel rather than on its own, and the total reflects the draw, the laboratory and the other markers included. On this page, the current price is shown with the Extended Metabolic panel details.
Because the value is hard to interpret alone. A short-window glycation marker is read against fasting glucose, insulin and HbA1c, and bundling also shares the cost of the blood draw, specimen handling and reporting across several markers instead of charging them to one.
Coverage varies by plan and by the reason the test was ordered, so the only reliable answer comes from your own plan. It is worth asking specifically how the test is billed when it is part of a panel rather than ordered alone.
The Extended Metabolic panel is HSA/FSA eligible. That does not change the price, it changes which dollars pay for it, so confirm the details with your account administrator if you are unsure how to submit the expense.
Comparing the two as line items is not very useful, since what you pay is driven by how the order is placed and what else is run at the same time. They also answer different questions, with fructosamine reflecting roughly two to three weeks and HbA1c roughly two to three months.
Fructosamine itself reflects weeks of glucose exposure, so a single meal does not meaningfully move it, but companion markers on the same panel may have their own requirements. Follow the preparation instructions issued with your specific order.
That is a clinical decision rather than a fixed rule, and it depends on why the marker was ordered. Because it reflects a short window, it is generally used to watch change over time, which means the cost of a testing cadence matters more than the cost of one draw.
It means your value sits outside the interval the laboratory uses for its comparison population, which may reflect higher or lower average glucose, and may also reflect protein turnover or other factors. It is an observation, not a diagnosis, and it is worth discussing with a clinician alongside the rest of the panel.
Not always. The assay is not standardised across laboratories in the way HbA1c is, so each report carries its own reference interval. Where possible, track the marker through the same laboratory and method so that changes between draws reflect your biology rather than the assay.